Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Philippe Moreau
Pomalidomide Plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone Alone for Patients With Relapsed and Refractory Multiple Myeloma (MM-003): A Randomised, Open-Label, Phase 3 Trial
The Lancet Oncology
Oncology
Myeloma Cell Self-Renewal Depends on JAG2 Expression and Is Mediated by IGF1 or SCF Loop
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Achievement of VGPR to Induction Therapy Is an Important Prognostic Factor for Longer PFS in the IFM 2005-01 Trial
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03)
Clinical Cancer Research
Cancer Research
Oncology
ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents
Clinical Cancer Research
Cancer Research
Oncology
Responses in Multiple Myeloma Should Be Assigned According to Serum, Not Urine, Free Light Chain Measurements
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Analysis of the Genomic Landscape of Multiple Myeloma Highlights Novel Prognostic Markers and Disease Subgroups
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Exome Sequencing Identifies Germline Variants in DIS3 in Familial Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Recommendations for Acquisition, Interpretation and Reporting of Whole Body Low Dose CT in Patients With Multiple Myeloma and Other Plasma Cell Disorders: A Report of the IMWG Bone Working Group
Blood Cancer Journal
Oncology
Hematology
Once- Versus Twice-Weekly Carfilzomib in Relapsed and Refractory Multiple Myeloma by Select Patient Characteristics: Phase 3 A.R.R.O.W. Study Subgroup Analysis
Blood Cancer Journal
Oncology
Hematology
1
2
3
›
